Track Real Time Price

According to ChemAnalyst, The Zidovudine Prices recorded an upward movement across major pharmaceutical markets during the second quarter of 2026. Price developments were shaped by firm demand for HIV treatment medicines, higher production costs, fluctuations in energy expenses, and changing raw material economics. Zidovudine, also known as azidothymidine (AZT), remains an established nucleoside reverse transcriptase inhibitor (NRTI) used as part of antiretroviral treatment regimens and in specific clinical applications. During Q2 2026, the Zidovudine Price Index increased in the United States, China, and Germany, although the underlying market dynamics differed across regions. In North America, stronger pharmaceutical demand and rising producer costs supported prices. In China, pharmaceutical demand strengthened while energy and environmental expenses introduced volatility into manufacturing economics. Meanwhile, European prices, particularly in Germany, increased amid higher pharmac...

  According to ChemAnalyst, global Zidovudine prices recorded a significant upward trend across key markets during the first quarter of 2026, supported by increasing production expenses, ongoing supply chain challenges, and steady demand from the pharmaceutical industry. As a vital antiretroviral drug widely used in the treatment and prevention of HIV, Zidovudine continues to play an essential role in healthcare systems worldwide. Throughout the quarter, market participants closely tracked fluctuations in raw material costs, manufacturing conditions, inflationary pressures, and government healthcare programs, all of which contributed to movements in the Zidovudine Price Index. Zidovudine Prices Analysis – Q1 2026 Overview of Global Zidovudine Market Trends The global Zidovudine market witnessed an upward pricing trajectory during Q1 2026 as manufacturers encountered increasing production expenses and supply chain challenges. Rising energy costs, inflationary pressures, transportat...